Skip to search formSkip to main contentSkip to account menu

brecanavir

Known as: (1S,2R)-3-((1,3-benzodioxol-5-ylsulfonyl)(2-methylpropyl)amino-2-hydroxy-1-((4-(2-methyl-4-thiazolyl)methoxy)phenyl)methylpropyl)carbamic acid, hexahydrofuro(2,3-b)furan-3yl ester, BCV 
A tyrosyl-based arylsulfonamide inhibitor of human immunodeficiency virus (HIV) protease.
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

BenzodioxolesCarbamates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Chronic urticaria: frequency of anti-HCV antibodies
Background Urticaria is defined as a skin disorder, clinically characterized by the presence of transient erythematous itchy… 
2017
2017
Split internal jugular vein: surgical and radiological implications.
2014
2014
Percutaneous Transluminal Angioplasty for Central Venous Disease in Dialysis Patients: Influence on Cardiac Function
Purpose Increased vascular access flow after percutaneous transluminal angioplasty (PTA) for central venous stenosis and… 
2014
2014
Appearance of ocular vestibular evoked myogenic potential elicited by bone-conducted vibration in a patient with CHARGE syndrome with aplasia of all semicircular canals.
Review
2013
Review
2013
Ultrasound-guided central venous access in infants and children
2011
2011
W3.5 Test retest reliability of vestibular evoked myogenic potentials
2007
2007
Preliminary safety and efficacy data of brecanavir, a novel HIV-1 protease inhibitor: 24 week data from study HPR10006.
BACKGROUND Brecanavir, a novel protease inhibitor (PI), has sub-nM in vitro antiviral activity against multi-PI-resistant HIV-1… 
2007
2007
Biological movement variability during the golf swing
This study quantified the level and effect of biological movement variability (BCV %) on the golf swing performance of 10 skilled… 
2006
2006
Single-Dose Safety and Pharmacokinetics of Brecanavir, a Novel Human Immunodeficiency Virus Protease Inhibitor
ABSTRACT Brecanavir (BCV, 640385) is a novel, potent protease inhibitor (PI) with low nanomolar 50% inhibitory concentrations… 
1998
1998
Bootstrapping Likelihood for Model Selection with Small Samples
Akaike s Information Criterion AIC derived from asymptotics of the maximum like lihood estimator is widely used in model… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)